UBE Corporation · TSE:4208
UBE — FY2018 Earnings Presentation
35 slides from UBE's earnings presentation, May 14, 2019
Slide 1: FY2018 Consolidated Results, FY2019 Consolidated Forecasts
FY2018 Consolidated Results FY2019 Consolidated Forecasts Explanatory material May 14, 2019
Slide 2: Contents
Contents FY2018 Consolidated Results FY2019 Consolidated Forecasts Reference 2
Slide 3: FY2018 Consolidated Results
FY2018 Consolidated Results 3
Slide 4: Scope of Consolidation
FY2018 Consolidated Results Scope of Consolidation End of FY 2017 End of FY 2018 Difference Item Notes (A) (B) （B) - （A) Number of + Oita Ube Co., Ltd. consolidated 70 71 1 + Repol S.L. subsidiaries Ube Concrete Co., Ltd. Number of equity method 24 25 1 + Ube Maxell Kyoto Co., Ltd. affiliates Tota
Slide 5: Environmental Factors: Naphtha Material Price
FY2018 Consolidated Results Environmental Factors FY2017 FY 2018 Difference Item (A) (B) (B) - (A) Exchange Rate Yen/$ 110.9 110.9 0.0 519 616 97 Naphtha CIF $/ｔ Domestic Yen/KL 42,000 49,400 7,400 Material Price Benzene (ACP) $/ｔ 826 764 (62) Australian $/ｔ 104.6 125.0 20.4 Coal (CIF) Yen/t 11,598
Slide 6: Major P/L Items
FY2018 Consolidated Results Major P/L Items (Billions of yen) FY2017 FY 2018 Difference Percentage Item (A) (B) (B) - (A) change Net sales 695.5 730.1 34.5 5.0% Operating profit 50.2 44.5 (5.6) (11.3)% Ordinary profit 50.7 47.8 (2.8) (5.7)% Profit attributable to 31.6 32.4 0.8 2.6% owners of parent
Slide 7: Net Sales and Operating Profit by Segment
FY2018 Consolidated Results Net Sales and Operating Profit by Segment (Billions of yen) FY2017 FY 2018 Difference Segment (A) (B) (B) - (A) Chemicals 305.4 314.9 9.5 Pharmaceutical 10.2 10.1 (0.0) Net sales Cement & Construction Materials 238.8 250.2 11.3 Machinery 90.1 97.2 7.1 Energy & Environment
Slide 8: Analysis - Total
FY2018 Consolidated Results Analysis - Total (Billions of yen) Net Sales Difference of operating profit Chemicals 9.5 840.0 +34.5 730.1 695.5 Pharmaceutical (0.0) Price ※1 (4.4) Cement & Construction Materials 11.3 合成ゴム 69.0 Machinery 7.1 420.0 Energy & Environment 4.4 Volume 3.1 Others 0.1 Adjustme
Slide 9: Analysis - Chemicals
FY2018 Consolidated Results Analysis - Chemicals (Billions of yen) Net Sales Difference of operating profit Nylon/Caprolactam chain 6.0 Price ※1 (4.1) +9.5 Synthetic rubber 1.8 合成ゴム 69.0 Battery Materials and Fine Chemicals (0.3) Polyimide and Specialty Products 1.4 Volume 2.0 etc カプロラクタム (6 0) Fixe
Slide 10: Analysis - Pharmaceutical
FY2018 Consolidated Results Analysis - Pharmaceutical (Billions of yen) Net Sales Difference of operating profit (0.0) Price ※1 (0.8) Volume 0.2 (0.8)% Decreased Fixed Cost and Others ※2 (0.6) Operating profit Total (1.2) (1.2) *1: Including both selling and purchase change (59.4)% Decreased *2: Inc
Slide 11: Analysis – Cement & Construction Materials
FY2018 Consolidated Results Analysis – Cement & Construction Materials (Billions of yen) Net Sales Difference of operating profit +11.3 Price ※1 1.3 Cement and Ready-mixed concrete 9.3 69.0 Construction materials and 3.5 Limestone related products Volume 1.2 etc (6 0) 4.8% Increased Fixed Cost and O
Slide 12: Analysis - Machinery
FY2018 Consolidated Results Analysis - Machinery (Billions of yen) Net Sales Difference of operating profit +7.1 Price ※1 (0.2) 69.0 Volume (0.0) (6 0) 7.9% Increased Fixed Cost and Others ※2 0.2 Operating profit Total (0.1) (0.1) *1: Including both selling and purchase change (1.8)% Decreased *2: I
Slide 13: Analysis – Energy & Environment
FY2018 Consolidated Results Analysis – Energy & Environment (Billions of yen) Net Sales Difference of operating profit +4.4 Price ※1 (0.5) Coal 2.3 69.0 Power 2.2 etc Volume (0.3) (6 0) 6.3% Increased Fixed Cost and Others ※2 1.0 Operating profit Total 0.2 +0.2 Coal (0.3) Power 0.5 *1: Including bot
Slide 14: Operating Profit – Profit attributable to owners of parent
FY2018 Consolidated Results Operating Profit – Profit attributable to owners of parent (Billions of yen) FY 2017 FY 2018 Difference Item (A) (B) (B) - (A) Operating profit 50.2 44.5 (5.6) Non-operating income/expenses 0.4 3.3 2.8 Net interests expenses (0.1) 0.9 1.1 Share of profit of entities accou
Slide 15: Consolidated Balance Sheet
FY2018 Consolidated Results Consolidated Balance Sheet (Billions of yen) End of FY 2017 End of FY 2018 Difference Item (A) (B) (B) - (A) Current assets 316.8 315.6 (1.1) Fixed assets 425.4 424.4 (0.9) Total assets 742.4 740.2 (2.1) Interest-bearing debts 195.5 187.2 (8.2) Other liabilities 210.0 198
Slide 16: Consolidated Statements of Cash Flows
FY2018 Consolidated Results Consolidated Statements of Cash Flows (Billions of yen) Item FY2017 FY 2018 Profit before income taxes 44.6 Depreciation and amortization 36.4 A.Cash flows from operating activities 73.3 50.4 Decrease workig capital (16.6) Income taxes paid (12.7) etc. B.Cash flows from i
Slide 17: FY2019 Consolidated Forecasts
FY2019 Consolidated Forecasts 17
Slide 18: Scope of Consolidation
FY2019 Consolidated Forecasts Scope of Consolidation End of FY 2018 End of FY 2019 Difference Item Notes (A) (B) （B) - （A) Number of consolidated 71 70 (1) － UBE Coal Trading, Ltd. subsidiaries Number of equity + CNSG ANHUI HONG SIFANG and UBE NEW method 25 26 1 MATERIAL TECHNOLOGY CO., LTD. affilia
Slide 19: Environmental Factors: Naphtha Material Price
FY2019 Consolidated Forecasts Environmental Factors FY 2018 FY 2019 Difference Item (A) (B) (B) - (A) Exchange Rate Yen/$ 110.9 110.0 (0.9) 616 570 (46) Naphtha CIF $/ｔ Material Price Domestic Yen/KL 49,400 45,600 (3,800) Benzene $/ｔ 764 720 (44) (ACP) Australian $/ｔ 125.0 125.0 0.0 Coal (CIF) Yen/t
Slide 20: Major P/L & B/S Items
FY2019 Consolidated Forecasts Major P/L & B/S Items (Billions of yen) FY 2018 FY 2019 Difference Percentage Item change (A) (B) (B) - (A) Net sales 730.1 760.0 29.9 4.1% Operating profit 44.5 47.0 2.5 5.5% Ordinary profit 47.8 47.0 (0.8) (1.8)% Profit attributable to 32.4 31.0 (1.4) (4.6)% owners of
Slide 21: Net Sales and Operating Profit by Segment
FY2019 Consolidated Forecasts Net Sales and Operating Profit by Segment (Billions of yen) FY 2018 FY 2019 Difference Segment (A) (B) (B) - (A) Chemicals 324.2 345.0 20.8 Net sales Cement & Construction Materials 321.0 330.0 9.0 Machinery 97.2 100.0 2.8 Others 4.9 5.0 0.1 Adjustment (17.3) (20.0) (2.
Slide 22: Analysis - Total
FY2019 Consolidated Forecasts Analysis - Total (Billions of yen) Net Sales Difference of operating profit 900.0 +29.9 730.1 760.0 Chemicals 20.8 Cement & Construction Materials 9.0 Price ※1 (0.3) Machinery 2.8 合成ゴム 69.0 450.0 Others 0.1 Adjustment (2.7) Volume 10.7 カプロラクタム (6 0) 0.0 4.1% Increased F
Slide 23: Analysis - Chemicals
FY2019 Consolidated Forecasts Analysis -Chemicals (Billions of yen) Net Sales Difference of operating profit +20.8 Nylon and Fine Chemicals 11.8 Synthetic rubber (4.0) Price ※1 (2.1) Specialty Products 6.7 合成ゴム 69.0 Pharmaceutical 1.9 etc Volume 9.6 カプロラクタム (6 0) 6.4% Increased Fixed Cost and Others
Slide 24: Analysis – Cement & Construction Materials
FY2019 Consolidated Forecasts Analysis – Cement & Construction Materials (Billions of yen) Net Sales Difference of operating profit Cement and Ready-mixed concrete (2.5) +9.0 Construction materials and 5.3 Limestone related products Price ※1 1.5 Coal 3.2 69.0 Power 2.4 etc Volume 1.2 (6 0) 2.8% Incr
Slide 25: Analysis – Machinery
FY2019 Consolidated Forecasts Analysis – Machinery (Billions of yen) Net Sales Difference of operating profit +2.8 Price ※1 0.3 69.0 Volume (0.1) 2.8% Increased (6 0) Fixed Cost and Others ※2 0.4 Operating Profit +0.6 Total 0.6 *1: Including both selling and purchase change 10.9% Increased *2: Inclu
Slide 26: Operating Profit – Profit attributable to owners of parent
FY2019 Consolidated Forecasts Operating Profit – Profit attributable to owners of parent (Billions of yen) FY 2018 FY 2019 Difference Item (A) (B) (B) - (A) Operating profit 44.5 47.0 2.5 Non-operating income/expenses 3.3 0.0 (3.3) Ordinaly profit 47.8 47.0 (0.8) Extraordinary income/losses (3.1) (3
Slide 27: Reference
Reference 27
Slide 28: Analysis of Operating Profit by Segment
Reference: FY2018 Consolidated Results Analysis of Operating Profit by Segment （Billions of yen） Operating profit Segment Fixed cost FY 2017 FY 2018 Difference Price Volume and others (A) (B) (B) - (A) *1 *2 Chemicals 28.9 23.7 (5.2) (4.1) 2.0 (3.1) Pharmaceutical 2.1 0.8 (1.2) (0.8) 0.2 (0.6) Cemen
Slide 29: Net Sales
Reference: FY2018 Consolidated Results Net Sales (Billions of yen) FY2018 Full-year Segment (Forecast) Progress 1Q 2Q 3Q 4Q Total Chemicals 73.5 78.1 83.0 80.2 314.9 320.0 98.4% Pharmaceutical 1.7 1.6 3.7 2.9 10.1 10.0 101.3% Cement & Construction 59.4 60.0 68.8 61.8 250.2 250.0 100.1% Materials Mac
Slide 30: Operating Profit
Reference: FY2018 Consolidated Results Operating Profit (Billions of yen) FY2018 Full-year Segment (Forecast) Progress 1Q 2Q 3Q 4Q Total Chemicals 3.6 4.6 7.6 7.8 23.7 22.5 105.6% Pharmaceutical (0.0) 0.0 0.8 (0.0) 0.8 0.5 171.0% Cement & Construction 2.0 2.5 3.9 3.3 11.8 12.5 95.1% Materials Machin
Slide 31: Net Sales and Operating Profit in Half Years by Segment
Reference: FY2019 Consolidated Forecasts Net Sales and Operating Profit in Half Years by Segment （Billions of yen） Net Sales Operating profit Segment First Second First Second Total Total half half half half Chemicals 167.5 177.5 345.0 10.5 16.0 26.5 Cement & Construction 162.5 167.5 330.0 6.5 8.5 1
Slide 32: Consolidated Key Indicators
Reference: FY2018 Consolidated Results Consolidated Key Indicators (Billions of yen) FY 2019 Item FY2017 FY 2018 (forecast) Capital investment 40.3 41.7 50.0 Depreciation and amortization 35.3 36.4 37.0 Research and development expenses 13.2 12.1 14.0 Adjusted operating profit 55.1 51.5 51.5 Interes
Slide 33: Consolidated Major Subsidiaries
Reference: FY2018 Consolidated Results Consolidated Major Subsidiaries (Billions of yen) Net Difference of Sales operating Subsidiaries and Affiliates Business profit FY 2018 from FY 2017 Manufacture and sales of caprolactam, ammonium sulfate, nylon, and UBE Corporation Europe, S.A. Unipersonal fine
Slide 34: Major Items for Capital Expenditure
Reference: FY2019 Consolidated Forecasts Major Items for Capital Expenditure Estimeated Segment Subject Place completion date Expand production capacity of Lithium-ion Sakai, Japan FY 2020 battery separator Chemicals Construct 5th pharmaceutical plant Ube, Japan FY 2021 Construct exhaust heat recove
Slide 35: Forward-looking statements disclaimer
This presentation material contains forward-looking statements concerning UBEʼs future plans, strategies, and performance. These forward-looking statements are not historical facts; rather, they represent assumptions and beliefs based on economic, financial, and competitive date currently available.